Company profile

Ticker
ACUR
Exchange
CEO
Robert B. Jones
Employees
Incorporated
Location
Fiscal year end
Former names
HALSEY DRUG CO INC/NEW
SEC CIK
IRS number
110853640

ACUR stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

14 Aug 20
25 Sep 20
31 Dec 20

News

Quarter (USD) Jun 20 Mar 20 Sep 19 Jun 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 16
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
2 Jan 20 Immanuel Thangaraj Common Stock Option exercise Aquire M No 0 83,333 0 209,525
2 Jan 20 Immanuel Thangaraj RSU Common Stock Grant Aquire A No 0 54,790 0 54,790
2 Jan 20 Immanuel Thangaraj RSU Common Stock Option exercise Dispose M No 0 83,333 0 0
2 Jan 20 Robert A Seiser Common Stock Option exercise Aquire M No 0 4,667 0 327,157
2 Jan 20 Robert A Seiser RSU Common Stock Option exercise Aquire M No 0.01 4,667 46.67 69,333
2 Jan 20 Robert B Jones Common Stock Option exercise Aquire M No 0 13,667 0 426,222
2 Jan 20 Robert B Jones RSU Common Stock Option exercise Aquire M No 0.01 13,667 136.67 177,333
2 Jan 20 James F Emigh Common Stock Option exercise Aquire M No 0 4,667 0 444,327
2 Jan 20 James F Emigh RSU Common Stock Option exercise Aquire M No 0.01 4,667 46.67 69,333
2 Jan 20 Peter A Clemens Common Stock Payment of exercise Dispose F No 0.23 3,090 710.7 361,377
0.0% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 1 0 NEW
Opened positions 1 0 NEW
Closed positions 0 1 EXIT
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 0 0
Total shares 780 0 NEW
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Lenox Wealth Advisors 780 $0 NEW
Largest transactions
Shares Bought/sold Change
Lenox Wealth Advisors 780 +780 NEW

Financial report summary

?
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: disbursement, fact, passed, publicly, twelve, unbilled, wholesale
Removed: amendment, Commission, comparative, detail, Sep, unpaid

Patents

GRANT
Utility
Methods and compositions for self-regulated release of active pharmaceutical ingredient
23 Jun 20
An abuse deterrent pharmaceutical composition including a pharmaceutically active ingredient; an acid soluble ingredient; and a buffering ingredient; wherein the acid soluble ingredient and the buffering ingredient retard release of the active pharmaceutical ingredient when the composition is ingested in excess of an intended dosage.
APP
Utility
Methods and Compositions for Interfering with Extraction or Conversion of a Drug Susceptible to Abuse
18 Jun 20
Effective methods and compositions to deter abuse of pharmaceutical products (e.g., orally administered pharmaceutical products) including but not limited to immediate release, sustained or extended release and delayed release formulations for drugs subject to abuse.
GRANT
Utility
Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse
7 Apr 20
Effective methods and compositions to deter abuse of pharmaceutical products (e.g., orally administered pharmaceutical products) including but not limited to immediate release, sustained or extended release and delayed release formulations for drugs subject to abuse.
GRANT
Utility
Methods and compositions for self-regulated release of active pharmaceutical ingredient
15 Oct 19
An abuse deterrent pharmaceutical composition including a pharmaceutically active ingredient; an acid soluble ingredient; and a buffering ingredient; wherein the acid soluble ingredient and the buffering ingredient retard release of the active pharmaceutical ingredient when the composition is ingested in excess of an intended dosage.